Harmony Biosciences Holdings, Inc. (HRMY) Financials

HRMY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.3 billion 361.5 million
Dec. 31, 2025 1.3 billion 401.4 million
Sept. 30, 2025 1.2 billion 373.1 million
June 30, 2025 1.1 billion 334.9 million

HRMY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 27.8 million 10.6 million
Dec. 31, 2025 126.0 million 10.2 million
Sept. 30, 2025 108.7 million 10.8 million
June 30, 2025 79.3 million 11.5 million

HRMY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 32.5 million
Dec. 31, 2025 22.5 million
Sept. 30, 2025 50.9 million
June 30, 2025 39.8 million

HRMY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 640.9 million 138.8 million 4.5 million
Dec. 31, 2025 775.3 million 148.2 million 4.5 million
Sept. 30, 2025 672.6 million 148.5 million 1.2 million
June 30, 2025 565.3 million 153.3 million 1.3 million

HRMY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 58.8 million
Dec. 31, 2025 58.7 million
Sept. 30, 2025 58.7 million
June 30, 2025 58.4 million

HRMY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 69.4 million 64.2 million 31.7 million
Dec. 31, 2025 107000 49.9 million 86.7 million 29.2 million
Sept. 30, 2025 71000 55.0 million 59.4 million 29.5 million
June 30, 2025 4000 50.2 million 64.0 million 30.1 million

HRMY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 215.4 million 44.5 million
Dec. 31, 2025 243.8 million 68.5 million
Sept. 30, 2025 239.5 million 59.7 million
June 30, 2025 200.5 million 38.2 million

HRMY

Price: $34.18

52 week price:
25.52
40.87

Payout Ratio Range:
-21799.51%
207.69%

Earnings Per Share: 2.48 USD

P/E Ratio: 12.16

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 87588

Market Capitalization: 1.9 billion

Links: